Novavax (NVAX) COVID Jab Gets Philippines Nod, Under Review in EU

Published on November 18, 2021

Novavax's (NVAX) secures approval for its COVID vaccine in the Philippines. The EMA begins reviewing the company's regulatory submission for its COVID vaccine. Evidently, the stock gains.

Continue reading on website
Other news

Women and entrepreneurship, the challenges that persist

November 18, 2021
Latin America has had an explosion of successful ventures in the last two years. However, boom has a pending task: to integrate more women.

Why to Bet on Artificial Intelligence ETFs With a Long-Term View

November 18, 2021
The global robotics technology market size is projected to reach $189.36 billion by 2027, at a CAGR of 13.5%, per Allied Market Research.